ArticleNature communications2024

Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies.

Sarah Figarol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.